Related Experiment Videos
Immunity against cancer: lessons learned from melanoma
A N Houghton1, J S Gold, N E Blachere
1Memorial Sloan-Kettering Cancer Center and Weill Medical School of Cornell University, 1275 York Avenue, New York, NY 10021, USA. a-houghton@ski.mskcc.org
Current Opinion in Immunology
|March 3, 2001
Summary
Advances in cancer immunology and immunotherapy largely stem from melanoma research. Scientists are uncovering the T cell and antibody immune repertoire active against melanoma, including previously unseen genomic mutations.
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Melanoma research has driven significant progress in human cancer immunology and immunotherapy.
- Understanding the immune system's response to melanoma is crucial for developing effective treatments.
Purpose of the Study:
- To elucidate the T cell and antibody immune repertoire against melanoma.
- To explore the immune system's recognition of novel targets, including mutations and previously hidden genomic elements.
Main Methods:
- Analysis of T cell repertoires.
- Characterization of antibody responses.
- Investigation of immune recognition of tumor-specific mutations.
Main Results:
- Initial characterization of the CD4(+) T cell repertoire active in melanoma.
- Identification of immune targets within melanoma, including mutations and normally "invisible" genomic regions.
Conclusions:
- The immune system possesses a broader repertoire against melanoma than previously understood.
- Further exploration of these immune targets could lead to novel cancer immunotherapy strategies.